TYCO'S $1.4 BIL. ACQUISITION OF KENDALL
This article was originally published in The Gray Sheet
Executive Summary
TYCO'S $1.4 BIL. ACQUISITION OF KENDALL will result in annual disposable medical product sales of over $730 mil. at the combined company. Under a definitive agreement announced July 14, Kendall, with $816 mil. in 1993 revenues, would be merged with Tyco's packing division to form a $1.2 bil. disposable medical and specialty products business segment. More than 80% (over $650 mil.) of Kendall's revenues come from disposable health care and related products; the product segment accounts for $80 mil. of Tyco's $400 mil. in packing division revenues.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.